# PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor

Study · id `cardio:ct-nct03401489` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03401489](<https://clinicaltrials.gov/study/NCT03401489>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03401489

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 120 participants.

## Technical summary

Registry record NCT03401489. Randomized; single masking; primary purpose prevention. Start 2020-07-14 (actual); primary completion 2024-02-28 (actual). Results posted on 2025-11-24.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT03401489, source copy `cardio:ctgov-nct03401489-2025-12-11`, retrieved 2026-10-26)
- Started: 2020-07-14 (actual) (ClinicalTrials.gov record NCT03401489, source copy `cardio:ctgov-nct03401489-2025-12-11`, retrieved 2026-10-26)
- Primary completion: 2024-02-28 (actual) (ClinicalTrials.gov record NCT03401489, source copy `cardio:ctgov-nct03401489-2025-12-11`, retrieved 2026-10-26)
- Completion: 2024-02-28 (actual) (ClinicalTrials.gov record NCT03401489, source copy `cardio:ctgov-nct03401489-2025-12-11`, retrieved 2026-10-26)
- Results first posted: 2025-11-24 (ClinicalTrials.gov record NCT03401489, source copy `cardio:ctgov-nct03401489-2025-12-11`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03401489, source copy `cardio:ctgov-nct03401489-2025-12-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03401489-2025-12-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor
- Condition: Blood Pressure
- Condition: Hypertension
- Condition: Mhealth
- Intervention (Device): PACESETTER
- Lead sponsor: Northern California Institute of Research and Education
- Lead sponsor class: OTHER
- Collaborator: University of South Carolina
- Collaborator class: OTHER
- Collaborator: Medical University of South Carolina
- Collaborator class: OTHER
- Collaborator: National Institute on Minority Health and Health Disparities (NIMHD)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Northern California Institute of Research and Education (`cardio:org-northern-california-institute-of-research-and-education`)
- Registry lists this organization as a collaborator: University of South Carolina (`cardio:org-university-of-south-carolina`)
- Registry lists this organization as a collaborator: Medical University of South Carolina (`cardio:org-medical-university-of-south-carolina`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor: A Randomized Trial (`cardio:pubmed-42622217`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 52bdbef71b0044f0afc4fde2beed73330916c548f5dd0236023ec3bf5b711676
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
